Interne link ProQR Announces Preclinical Proof of Concept Data for AX-0810 Axiomer™ RNA Editing Program Targeting NTCP for Cholestatic Diseases mei 08, 2024 om 12:00 PM UTC
Interne link ProQR Nominates Martin Maier, PhD to Board and Announces Annual Meeting of Shareholders to be Held May 22, 2024 april 23, 2024 om 11:00 AM UTC
Interne link ProQR Highlights Upcoming Presentations on Axiomer™ RNA Editing at ASGCT 27th Annual Meeting april 22, 2024 om 08:31 PM UTC
Interne link ProQR Achieves Successful Defense of New Challenge to its Axiomer™ IP Portfolio april 19, 2024 om 11:00 AM UTC
Interne link ProQR Announces Year End 2023 Operating and Financial Results maart 13, 2024 om 11:00 AM UTC
Interne link ProQR Announces Japanese Axiomer™ Patent Upheld Following Opposition Against Its Leading IP Estate for ADAR-mediated RNA Editing februari 15, 2024 om 12:00 PM UTC
Interne link ProQR Highlights New Platform Data from Presentation on Axiomer™ RNA Editing Technology at Deaminet 2024 januari 19, 2024 om 12:00 PM UTC
Interne link ProQR and Rett Syndrome Research Trust Join Forces with Axiomer™ RNA Editing Collaboration januari 05, 2024 om 12:00 PM UTC